Hungary curbs drug company advertisingBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7292.947/a (Published 21 April 2001) Cite this as: BMJ 2001;322:947
- Carl Kovac
Hungary's pharmaceutical manufacturers are facing a clampdown on the methods they use to advertise and market their products to doctors. A health ministry decree, due to become effective within the next few weeks, will drastically limit what has been termed “rampant marketing” by manufacturers. “The era of uncontrolled drug advertising, unsupervised vaccine programmes, leaflets promoting pharmacies, and medications jamming mailboxes is over,” said health minister István Mikola.
The new decree is seen by the health ministry as essential to bringing down the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial